SCYNEXIS, Inc. - stock earnings
SCYX Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -1.8 million USD | 1.8 million USD |
| 2023Q2 | 122.3 million USD | 131.5 million USD |
| 2023Q1 | -55.6 million USD | 1.1 million USD |
| 2022Q4 | -19.1 million USD | 1.5 million USD |
| 2022Q3 | -37.2 million USD | 1.6 million USD |
| 2022Q2 | -4.8 million USD | 1.3 million USD |
| 2022Q1 | -5.5 million USD | 687000 USD |
| 2021Q4 | -29.2 million USD | 597000 USD |
| 2021Q3 | -605000 USD | 516000 USD |
| 2021Q2 | 1.7 million USD | ? USD |
| 2021Q1 | -4.7 million USD | 12.1 million USD |
| 2020Q4 | -42.7 million USD | ? USD |
| 2020Q3 | 909000 USD | ? USD |
| 2020Q2 | -6.4 million USD | ? USD |
| 2020Q1 | -7.0 million USD | ? USD |
| 2019Q4 | -14.5 million USD | ? USD |
| 2019Q3 | -7.9 million USD | ? USD |
| 2019Q2 | -8.4 million USD | 57000 USD |
| 2019Q1 | -22.9 million USD | 64000 USD |
| 2018Q4 | 1.9 million USD | 64000 USD |
| 2018Q3 | 351000 USD | 64000 USD |
| 2018Q2 | -10.8 million USD | 64000 USD |
| 2018Q1 | -4.0 million USD | 64000 USD |
| 2017Q4 | -7.6 million USD | 64000 USD |
| 2017Q3 | -8.4 million USD | 64000 USD |
| 2017Q2 | -4.2 million USD | 64000 USD |
| 2017Q1 | -4.9 million USD | 64000 USD |
| 2016Q4 | -3.4 million USD | 64000 USD |
| 2016Q3 | -11.2 million USD | 64000 USD |
| 2016Q2 | -8.1 million USD | 64000 USD |
| 2016Q1 | -7.2 million USD | 64000 USD |
| 2015Q4 | -8.4 million USD | 64000 USD |
| 2015Q3 | -8.4 million USD | 64000 USD |
| 2015Q2 | -9.5 million USD | 64000 USD |
| 2015Q1 | -6.4 million USD | 3.3 million USD |
| 2014Q4 | -3.1 million USD | 5.3 million USD |
| 2014Q3 | -3.8 million USD | 4.4 million USD |
| 2014Q2 | 2.2 million USD | 4.6 million USD |
| 2014Q1 | 412000 USD | 4.7 million USD |
| 2013Q4 | -21.7 million USD | 3.7 million USD |
| 2013Q3 | -4.0 million USD | 4.2 million USD |
| 2013Q2 | -2.7 million USD | 4.2 million USD |
| 2013Q1 | -2.1 million USD | 4.8 million USD |
| 2012Q4 | ? USD | 16.8 million USD |
SCYX Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 72.2 million USD | 135.9 million USD |
| 2022 | -62.8 million USD | 5.1 million USD |
| 2021 | -32.9 million USD | 13.2 million USD |
| 2020 | -55.2 million USD | 12.1 million USD |
| 2019 | -55.2 million USD | 121000 USD |
| 2018 | -12.5 million USD | 257000 USD |
| 2017 | -25.1 million USD | 257000 USD |
| 2016 | -30.0 million USD | 257000 USD |
| 2015 | -32.6 million USD | 257000 USD |
| 2014 | -4.2 million USD | 1.3 million USD |
| 2013 | -30.5 million USD | 16.9 million USD |
| 2012 | -11.5 million USD | 16.8 million USD |
SCYX
Price: $1.72
52 week price:
Earnings Per Share: 1.49 USD
P/E Ratio: 1.33
Exchange: NGM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 45800
Ebitda: -8.0 millionMarket Capitalization: 60.6 million